HeartFlow

VP, Health Economics and Access Strategy

Mountain View, California, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Technology, Healthcare Services, Health EconomicsIndustries

Position Overview

  • Location Type: Remote
  • Employment Type: Full-time
  • Salary: Not specified

Heartflow is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest Pain Guidelines called the Heartflow FFRCT Analysis—provides a color-coded, 3D model of a patient’s coronary arteries indicating the impact blockages have on blood flow to the heart. Heartflow is the first AI-driven non-invasive integrated heart care solution across the CCTA pathway that helps clinicians identify stenoses in the coronary arteries (RoadMap™ Analysis), assess coronary blood flow (FFRCT Analysis), and characterize and quantify coronary atherosclerosis (Plaque Analysis). Our pipeline of products is growing and so is our team; join us in helping to revolutionize precision heartcare.

Heartflow is a VC-backed company that has received international recognition for exceptional strides in healthcare innovation, is supported by medical societies around the world, cleared for use in the US, UK, Europe, Japan and Canada, and has been used for more than 400,000 patients worldwide. The Vice President of Health Economics and Market Access Strategy will lead the development and execution of comprehensive strategies to secure coding, coverage, and payment for Heartflow’s future portfolio of products and services aimed at the early diagnosis of individuals at risk for coronary artery disease. In collaboration with the SVP of Market Access and Reimbursement, this role is responsible for both strategic and operational aspects of market access, including direct engagement with providers, professional societies, government and commercial payers, and other key stakeholders.

Responsibilities

  • Develop and execute a comprehensive health economics and market access strategy across HeartFlow’s portfolio, driving cost-effectiveness analyses in collaboration with internal teams and external experts.
  • Lead market access initiatives in partnership with the SVP of Market Access & Reimbursement, securing coding, coverage, and payment for future products through engagement with physician specialty societies, CMS, USPSTF, AMA, and other key stakeholders.
  • Align market access insights with organizational priorities, ensuring internal and external stakeholders are informed and equipped to support payment advocacy and expansion into new OUS markets.
  • Design compelling communication tools that articulate the clinical and economic value of HeartFlow’s technologies, including refined economic models, HTA submissions, and payer-focused clinical dossiers.
  • Drive evidence generation strategies with government affairs and clinical teams, shaping materials that strengthen HeartFlow’s value proposition with policymakers and regulatory bodies.

Requirements

  • Not specified

Application Instructions

  • Not specified

Skills

Health Economics
Market Access Strategy
Coding and Reimbursement
Stakeholder Engagement
Healthcare Policy
Strategic Planning

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters
2010Year Founded
$858.5MTotal Funding
SERIES_FCompany Stage
HealthcareIndustries
501-1,000Employees

Benefits

Remote Work Options
Stock Options
401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.
Algorithmic bias in AI models could lead to inaccurate diagnoses.
Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.
HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.
HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.
The global non-invasive cardiac imaging market is projected to grow significantly.
HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI